Michael T. Parsons

QIMR Berghofer Medical Research Institute

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 21 papers. Top paper: “Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants”.

Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants

Genetics in Medicine(2021)10.1016/j.gim.2021.08.016

N/A

1.2DataRank · unranked

31 citations

Christoph Engel, Miguel de la Hoya, Paolo Peterlongo, Drakoulis Yannoukakos, Luca Livraghi +56 more

Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants

Journal of Clinical Oncology(2022)10.1200/jco.21.02112

N/A

0.851DataRank · unranked

290 citations

Valentina Silvestri, Goska Leslie, Timothy R. Rebbeck, Susan L. Neuhausen, John L. Hopper +95 more

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel

The American Journal of Human Genetics(2024)10.1016/j.ajhg.2024.07.013

N/A

0.689DataRank · unranked

98 citations

Miguel de la Hoya, Marcy E. Richardson, Emma Tudini, Michael Anderson, Windy Berkofsky-Fessler +38 more

Contribution of mRNA Splicing to Mismatch Repair Gene Sequence Variant Interpretation

Frontiers in Genetics(2020)10.3389/fgene.2020.00798

N/A

0.470DataRank · unranked

22 citations

Rhiannon Walters, Michael T. Parsons, Troy Dumenil, Mark Drost, Yvonne Tiersma +5 more

Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

British Journal of Cancer(2023)10.1038/s41416-023-02263-5

N/A

0.449DataRank · unranked

19 citations

Susan J. Ramus, Melissa C. Southey, Nicola S. Meagher, Andreas Hadjisavvas, Esther M. John +87 more

Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification

Nature Communications(2025)10.1038/s41467-025-59979-6

N/A

0.330DataRank · unranked

8 citations

Denise G O'Mahony, Michael T. Parsons, Leila Dorling, Joe Dennis, Nicholas Boddicker +94 more

Co-observation of germline pathogenic variants in breast cancer predisposition genes: Results from analysis of the BRIDGES sequencing dataset

The American Journal of Human Genetics(2024)10.1016/j.ajhg.2024.07.004

N/A

0.330DataRank · unranked

8 citations

Kyriaki Michailidou, Michael T. Parsons, Cristina Fortuño, Manjeet K. Bolla, Qin Wang +95 more

PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants

npj Breast Cancer(2023)10.1038/s41523-023-00546-x

N/A

0.312DataRank · unranked

7 citations

Anna Morra, Sofia Khan, Daniel R. Barnes, Manjeet K. Bolla, Joe Dennis +65 more

Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification

medRxiv(2024)10.1101/2024.09.04.24313051

N/A

0.208DataRank · unranked

3 citations

Denise G O'Mahony, Michael T. Parsons, Leila Dorling, Joe Dennis, Nicholas Boddicker +95 more

APPLICATION OF THE ACMG/AMP FRAMEWORK TO CAPTURE EVIDENCE RELEVANT TO PREDICTED AND OBSERVED IMPACT ON SPLICING: RECOMMENDATIONS FROM THE CLINGEN SVI SPLICING SUBGROUP

medRxiv(2023)10.1101/2023.02.24.23286431

N/A

0DataRank · unranked

17 citations

Miguel de la Hoya, George A. R. Wiggins, Amanda Lindy, Lisa M. Vincent, Michael T. Parsons +11 more

Childhood, adolescent, and young adulthood cancer risk in BRCA1 or BRCA2 pathogenic variant carriers

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae306

N/A

0DataRank · unranked

7 citations

Laura Madanat‐Harjuoja, Goska Leslie, Daniel R. Barnes, Manjeet K. Bolla, Joe Dennis +68 more

Challenges and approaches to calibrating patient phenotype as evidence for cancer gene variant classification under ACMG/AMP guidelines

Human Molecular Genetics(2024)10.1093/hmg/ddae009

N/A

0DataRank · unranked

7 citations

Kyriaki Michailidou, Michael T. Parsons, Jill S. Dolinsky, Tina Pesaran, Amal Yussuf +11 more

Atypical cancer risk profile in carriers of Italian founder BRCA1 variant p.His1673del: Implications for classification and clinical management

Cancer Medicine(2024)10.1002/cam4.70114

N/A

0DataRank · unranked

3 citations

Cristina Fortuño, Laura Caleca, Bing Feng, Courtney Carroll, Michael T. Parsons +27 more

Polygenic risk score for breast cancer risk prediction in Asian BRCA1 and BRCA2 pathogenic variants carriers

npj Breast Cancer(2025)10.1038/s41523-025-00820-0

N/A

0DataRank · unranked

2 citations

Joe Dennis, Hai‐Lin Park, Sung-Won Kim, Jong Won Lee, Tiara Hassan +21 more

The SeqSplice multiplexed minigene splicing assay for characterization and quantitation of variant-induced BRCA1 and BRCA2 splice isoforms

Genome Research(2025)10.1101/gr.279557.124

N/A

0DataRank · unranked

0 citations

Michael T. Parsons, Gemma Moir-Meyer, Troy Dumenil, Gemma Montalban, Erica Lin +7 more

Considerations in assessing germline variant pathogenicity using cosegregation analysis

Genetics in Medicine(2020)10.1038/s41436-020-0920-4

N/A

0DataRank · unranked

40 citations

Michael T. Parsons, Amanda B. Spurdle, David E. Goldgar, Bing Feng, Sophie Belman

Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer

npj Breast Cancer(2020)10.1038/s41523-020-00185-6

N/A

0DataRank · unranked

10 citations

Sofia Khan, Rainer Fagerholm, Kristiina Aittomäki, Julie M. Cunningham, Joe Dennis +39 more

PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants

Research Square(2022)10.21203/rs.3.rs-2269143/v1

N/A

0DataRank · unranked

0 citations

Anna Morra, Sofia Khan, Daniel R. Barnes, Manjeet K. Bolla, Joe Dennis +64 more

Using the ACMG/AMP framework to capture evidence related to predicted and observed impact on splicing: Recommendations from the ClinGen SVI Splicing Subgroup

The American Journal of Human Genetics(2023)10.1016/j.ajhg.2023.06.002

N/A

0DataRank · unranked

315 citations

Miguel de la Hoya, George A. R. Wiggins, Amanda Lindy, Lisa M. Vincent, Michael T. Parsons +28 more

SpliceAI-10k calculator for the prediction of pseudoexonization, intron retention, and exon deletion

Bioinformatics(2023)10.1093/bioinformatics/btad179

N/A

0DataRank · unranked

26 citations

Aimee L. Davidson, Miguel de la Hoya, Michael T. Parsons, Dylan M. Glubb, Olga Kondrashova +2 more

A Likelihood Ratio Approach for Utilizing Case-Control Data in the Clinical Classification of Rare Sequence Variants: Application to BRCA1 and BRCA2

Human Mutation(2023)10.1155/2023/9961341

N/A

0DataRank · unranked

7 citations

Denise G O'Mahony, Michael T. Parsons, Hongyan Li, Joe Dennis, Kristiina Aittomäkkiki +95 more